NCT01024374

Brief Summary

Clinical single-blind randomized comparison with the overall objective of evaluating the clinical efficacy of the products Nutracort lotion and Nutracort cream in the treatment of seborrheic dermatitis on the face. Will be held clinical and perceived efficacy assessment and instrumental measurements. Each product will be applied at half face for 7 consecutive days and all applications will be monitored in the research site. 60 volunteers will be recruited. Evaluations will be held at the following times: T0 - before the initial application of the product; T1 - 24 hours after starting treatment, T2 - 48 hours after starting treatment, T3 - 72 hours after initiation of treatment, T4 - 96 hours after the start treatment, T7 - 7 days after initiation of treatment.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 2, 2009

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2010

Completed
Last Updated

December 2, 2009

Status Verified

December 1, 2009

First QC Date

November 30, 2009

Last Update Submit

December 1, 2009

Conditions

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Healthy subjects with seborrheic dermatitis on both sides of the face, both sexes, aged 18 to 60 years, skin types I through IV.

You may qualify if:

  • Healthy subjects
  • Subjects with seborrheic dermatitis on both sides of the face
  • both sexes
  • aged 18 to 60 years
  • skin types I through IV.

You may not qualify if:

  • pregnancy / lactation
  • skin condition in the area of application of the product
  • diabetes
  • immune insufficiency
  • subjects that are using systemic corticoids
  • subjects that are using immunosuppressors
  • skin diseases: vitiligo, psoriasis, lupus, atopic dermatitis
  • history of reaction to the product category
  • other diseases or medications that might interfere directly in the study or endanger the health of the subject

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dermatitis, Seborrheic

Condition Hierarchy (Ancestors)

DermatitisSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland DiseasesSkin Diseases, EczematousSkin Diseases, Papulosquamous

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 30, 2009

First Posted

December 2, 2009

Study Start

April 1, 2010

Last Updated

December 2, 2009

Record last verified: 2009-12